Finance

Lists
NHP:NASDAQ
National Healthcare Properties Inc Class A
$16.09
-0.19%
(-0.030) 1D
$16.09
0.00% (0.00)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NHP...
Open
$16.22
High
$16.55
Low
$15.99
Mkt. cap
712.38M
Avg. vol.
639.45K
Volume
598.44K
Dividend
1.86%
Quarterly dividend
$0.08
Ex-dividend date
Jul 15, 2026
52-wk high
$17.44
52-wk low
$11.25
EPS
-$0.78
Shares outstanding
44.28M
No. of employees
31
Open
$16.22
High
$16.55
Low
$15.99
Mkt. cap
712.38M
Avg. vol.
639.45K
Volume
598.44K
Dividend
1.86%
Quarterly dividend
$0.08
Ex-dividend date
Jul 15, 2026
52-wk high
$17.44
52-wk low
$11.25
EPS
-$0.78
Shares outstanding
44.28M
No. of employees
31
News stories
From web sources and news partners
About National Healthcare Properties Inc Class A
CEO-
Employees31
Founded2012
Headquarters-
SectorReal estate investment trust
Websitenhpreit.com
Analyst ratings
Based on 7 analysts giving stock ratings to NHP in the past 3 months
Buy
Buy
4
Hold
3
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for NHP in the last 3 months.
Highest
Current $16.09
$22.00 (+36.73%)
Average
$18.83 (+17.03%)
Lowest
$16.00 (-0.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Carroll
RBC Capital
Hold
Maintained
$17.00
+5.7%
10/01/2026
Austin Wurschmidt
KeyBanc
Hold
Reiterated
-
-
09/30/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
$19.00
+18.1%
09/01/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
$16.00
-0.6%
08/20/2026
Wes Golladay
Robert W. Baird
Buy
Maintained
$18.00
+11.9%
08/20/2026
Aaron Hecht
Citizens JMP
Buy
Maintained
$21.00
+30.5%
08/10/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
$22.00
+36.7%
08/05/2026
Juan C. Sanabria
BMO Capital
Hold
Initiated
$17.00
+5.7%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
86.03M
84.48M
86.28M
87.53M
Cost of goods sold
53.94M
52.38M
52.92M
54.12M
Cost of revenue
53.94M
52.38M
52.92M
54.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
5.64M
5.47M
6.60M
Operating expense
23.70M
23.63M
23.20M
24.42M
Total operating expenses
77.64M
76.01M
76.12M
78.53M
Operating income
8.39M
8.47M
10.16M
9.00M
Other non operating income
-77.00K
-26.00K
189.00K
-47.00K
EBT including unusual items
-12.47M
-22.70M
-4.20M
-5.34M
EBT excluding unusual items
-6.45M
-7.65M
-4.15M
-1.43M
Income tax expense
66.00K
101.00K
77.00K
47.00K
Effective tax rate
-0.53%
-0.44%
-1.83%
-0.88%
Other operating expenses
-
-
-
-
Net income
-12.56M
-22.70M
-4.31M
-5.36M
Net profit margin
-14.59%
-26.87%
-4.99%
-6.12%
Earnings per share
-
-
-
-0.07
Interest and investment income
294.00K
-
171.00K
2.34M
Interest expense
-15.06M
-16.10M
-14.67M
-12.72M
Net interest expenses
-14.77M
-16.10M
-14.50M
-10.38M
Depreciation and amortization charges
18.03M
17.99M
17.74M
17.81M
EBITDA
26.24M
26.33M
27.75M
26.66M
Gain or loss from assets sale
-626.00K
467.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps